Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Zhang WR, Liu X, Zhong QZ, Wu T, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Yin L, Qi SN, Li YX.
Zhang WR, et al. Among authors: zhang ww.
Cancer Med. 2024 Jan;13(1):e6899. doi: 10.1002/cam4.6899. Epub 2024 Jan 5.
Cancer Med. 2024.
PMID: 38180169
Free PMC article.